Literature DB >> 25239883

Remission of rheumatoid arthritis on brentuximab vedotin.

Pankit Vachhani1, Nilanjana Bose1, James P Brodeur1, Beata Holkova2, Prithviraj Bose3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25239883      PMCID： PMC6410943          DOI： 10.1093/rheumatology/keu374

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

Review 1.  The pathogenesis of rheumatoid arthritis.

Authors:  Iain B McInnes; Georg Schett
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

2.  Kinase inhibition--a new approach to the treatment of rheumatoid arthritis.

Authors:  David A Fox
Journal:  N Engl J Med       Date:  2012-08-09       Impact factor: 91.245

3.  In rheumatoid arthritis soluble CD30 ligand is present at high levels and induces apoptosis of CD30(+)T cells.

Authors:  Elisa Tinazzi; Alessandro Barbieri; Antonella Rigo; Giuseppe Patuzzo; Ruggero Beri; Roberto Gerli; Giuseppe Argentino; Antonio Puccetti; Claudio Lunardi
Journal:  Immunol Lett       Date:  2014-01-18       Impact factor: 3.685

4.  CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.

Authors:  R Gerli; C Pitzalis; O Bistoni; B Falini; V Costantini; A Russano; C Lunardi
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 5.  Brentuximab vedotin.

Authors:  Changchun Deng; Beiqing Pan; Owen A O'Connor
Journal:  Clin Cancer Res       Date:  2012-11-15       Impact factor: 12.531

Review 6.  Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases.

Authors:  Ezogelin Oflazoglu; Iqbal S Grewal; Hanspeter Gerber
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

7.  High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints.

Authors:  R Gerli; C Muscat; O Bistoni; B Falini; C Tomassini; E Agea; R Tognellini; P Biagini; A Bertotto
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330
  7 in total
  2 in total

1.  Production of insulin antibody associated with relapsed hodgkin's lymphoma.

Authors:  Masatoshi Ikeda; Masaki Fujimura; Kentaro Kurosawa; Shunsuke Tsugawa; Yui Sakuramachi; Kiyoko Takano; Shintaro Okamura; Masako Kitatani; Futoshi Iioka; Satoru Tsujii; Yasuaki Hayashino
Journal:  Diabetol Int       Date:  2021-10-16

2.  Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD).

Authors:  Yasunobu Sekiguchi; Hiroko Iizuka; Haruko Takizawa; Keiji Sugimoto; Sakura Sakajiri; Tadaaki Inano; Yasutaka Fukuda; Syuichi Shirane; Yasuharu Hamano; Shigeki Tomita; Hiroshi Izumi; Mitsuo Okubo; Noriko Nakamura; Tomohiro Sawada; Naoya Sekiguchi; Masaaki Noguchi
Journal:  Intern Med       Date:  2020-05-26       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.